Development and validation of CT imaging–based preoperative nomogram in the prediction of unfavorable high-grade small renal masses

References

• Kane CJ, Mallin K, Ritchey J, Cooperberg MR, Carroll PR. Renal cell cancer stage migration: analysis of the National cancer data base. Cancer. 2008;113(1):78–83. doi:10.1002/cncr.2351818491376
   PubMed Web of Science ®Google Scholar
• Bhindi B, Thompson RH, Lohse CM, et al. The probability of aggressive versus indolent histology based on renal tumor size: implications for surveillance and treatment. Eur Urol. 2018;36(6_suppl):704.
   Google Scholar
• Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst. 2007;98(18):569–570.
   Google Scholar
• Remzi M, Ozsoy M, Klingler HC, et al. Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter. J Urol. 2006;176(3):896–899. doi:10.1016/j.juro.2006.04.04716890647
   PubMed Web of Science ®Google Scholar
• Finelli A, Ismaila N, Bro B, et al. Management of small renal masses: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2017;35(6):668. doi:10.1200/JCO.2016.69.964528095147
   PubMed Web of Science ®Google Scholar
• Campbell S, Uzzo RG, Allaf ME, et al. Renal mass and localized renal cancer: AUA guideline. J Urol. 2017;198(3):520. doi:10.1016/j.juro.2017.03.07728479239
   PubMed Web of Science ®Google Scholar
• Thompson RH, Hill JR, Babayev Y, et al. Metastatic renal cell carcinoma risk according to tumor size. J Urol. 2009;182(1):41–45. doi:10.1016/j.juro.2009.02.12819450840
   PubMed Web of Science ®Google Scholar
• Umbreit EC, Shimko MS, Childs MA, et al. Metastatic potential of a renal mass according to original tumour size at presentation. BJU Int. 2011;109(2):194.
   PubMedGoogle Scholar
• Ball MW, Bezerra SM, Gorin MA, et al. Grade heterogeneity in small renal masses: potential implications for renal mass biopsy. J Urol. 2015;193(1):36–40. doi:10.1016/j.juro.2014.06.06724960470
   PubMed Web of Science ®Google Scholar
• Lane BR, Samplaski MK, Herts BR, Zhou M, Novick AC, Campbell SC. Renal mass biopsy–a renaissance. J Urol. 2008;179(1):20–27. doi:10.1016/j.juro.2007.08.12417997455
   PubMed Web of Science ®Google Scholar
• Volpe A, Finelli A, Gill IS, et al. Rationale for percutaneous biopsy and histologic characterisation of renal tumours. Eur Urol. 2012;62(3):491–504. doi:10.1016/j.eururo.2012.05.00922633318
   PubMed Web of Science ®Google Scholar
• Saroha S, Uzzo RG, Plimack ER, Ruth K, Alsaleem T. Lymphopenia is an independent predictor of inferior outcome in clear cell renal carcinoma. J Urol. 2013;189(2):454–461. doi:10.1016/j.juro.2012.09.16623041457
   PubMed Web of Science ®Google Scholar
• Karlo CA, Kou L, Di PP, et al. Renal cell carcinoma: a nomogram for the CT imaging-inclusive prediction of indolent, non-clear cell renal cortical tumours. Eur J Cancer. 2016;59:57–64. doi:10.1016/j.ejca.2016.02.01227016623
   PubMed Web of Science ®Google Scholar
• Novara G, Martignoni G, Artibani W, Ficarra V. Grading systems in renal cell carcinoma. J Urol. 2007;177(2):430–436. doi:10.1016/j.juro.2006.09.03417222604
   PubMed Web of Science ®Google Scholar
• Sauerbrei W, Royston P, Binder H. Selection of important variables and determination of functional form for continuous predictors in multivariable model building. Stat Med. 2007;26(30):5512–5528. doi:10.1002/sim.314818058845
   PubMed Web of Science ®Google Scholar
• Russo P. Should elective partial nephrectomy be performed for renal cell carcinoma >4 cm in size. Nat Clin Pract Urol. 2008;5(9):482–483. doi:10.1038/ncpuro117718648330
   PubMedGoogle Scholar
• Thompson RH, Kurta JM, Kaag M, et al. Tumor size is associated with malignant potential in renal cell carcinoma cases. J Urol. 2009;181(5):2033–2036. doi:10.1016/j.juro.2009.01.02719286217
   PubMed Web of Science ®Google Scholar
• Jeon HG, Seo SI, Jeong BC, et al. Percutaneous kidney biopsy for a small renal mass: a critical appraisal of results. J Urol. 2016;195(3):568–573. doi:10.1016/j.juro.2015.09.07326410732
   PubMed Web of Science ®Google Scholar
• Leveridge MJ, Finelli A, Kachura JR, et al. Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy. Eur Urol. 2011;60(3):578. doi:10.1016/j.eururo.2011.06.02121704449
   PubMed Web of Science ®Google Scholar
• Patel HD, Johnson MH, Pierorazio PM, et al. Diagnostic accuracy and risks of biopsy in the diagnosis of a renal mass suspicious for localized renal cell carcinoma: systematic review of the literature. J Urol. 2016;195(5):1340–1347. doi:10.1016/j.juro.2015.11.02926901507
   PubMed Web of Science ®Google Scholar
• Wang R, Jr JSW, Jr DPW, Higgins EJ, Hafez KS. Accuracy of percutaneous core biopsy in management of small renal masses. Urology. 2009;73(3):586–590. doi:10.1016/j.urology.2008.08.51919118884
   PubMed Web of Science ®Google Scholar
• Blumenfeld AJ, Guru K, Fuchs GJ, Kim HL. Percutaneous biopsy of renal cell carcinoma underestimates nuclear grade. Urology. 2010;76(3):610–613. doi:10.1016/j.urology.2009.09.09520163843
   PubMed Web of Science ®Google Scholar
• Lane BR, Babineau D, Kattan MW, et al. A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy. J Urol. 2007;178(2):429–434. doi:10.1016/j.juro.2007.03.10617561141
   PubMed Web of Science ®Google Scholar
• Jeldres C, Sun M, Liberman D, et al. Can renal mass biopsy assessment of tumor grade be safely substituted for by a predictive model. J Urol. 2009;182(1):2585–2589. doi:10.1016/j.juro.2009.08.05319836799
   PubMedGoogle Scholar
• Kutikov A, Smaldone MC, Egleston BL, et al. Anatomic features of enhancing renal masses predict malignant and high-grade pathology: a preoperative nomogram using the RENAL nephrometry score. J Urol. 2011;60(2):241–248.
   Google Scholar
• Raj GV, Thompson RH, Leibovich BC, Blute ML, Russo P, Kattan MW. Preoperative nomogram predicting 12-year probability of metastatic renal cancer. J Urol. 2008;179(6):2146. doi:10.1016/j.juro.2008.01.10118423735
   PubMed Web of Science ®Google Scholar
• Ball MW, Gorin MA, Bhayani SB, et al. Preoperative predictors of malignancy and unfavorable pathology for clinical T1a tumors treated with partial nephrectomy: a multi-institutional analysis. Urol Oncol. 2015;33(3):112.e9. doi:10.1016/j.urolonc.2014.11.003
   PubMed Web of Science ®Google Scholar
• Schachter LR, Bach AM, Snyder ME, Kattan MW, Russo P. The impact of tumour location on the histological subtype of renal cortical tumours. BJU Int. 2006;98(1):63–66. doi:10.1111/j.1464-410X.2006.06432.x16831144
   PubMed Web of Science ®Google Scholar
• Venkatesh R, Weld K, Ames CD, et al. Laparoscopic partial nephrectomy for renal masses: effect of tumor location. Urology. 2006;67(6):1169–1174. doi:10.1016/j.urology.2006.01.08916765174
   PubMed Web of Science ®Google Scholar
• Mehrazin R, Uzzo RG, Kutikov A, et al. Lymphopenia is an independent predictor of inferior outcome in papillary renal cell carcinoma. Urol Oncol. 2015;191(4):e321–e322.
   Google Scholar
• Viers BR, Thompson RH, Boorjian SA, Lohse CM, Leibovich BC, Tollefson MK. Preoperative neutrophil-lymphocyte ratio predicts death among patients with localized clear cell renal carcinoma undergoing nephrectomy. Urol Oncol. 2014;32(8):1277–1284. doi:10.1016/j.urolonc.2014.05.01425017696
   PubMed Web of Science ®Google Scholar